KDR and metastatic melanoma: Recently, we demonstrated that hypoxia induces an autocrine aggressive loop in Hs294T metastatic melanoma cells involving VEGF and VEGF-R2, and Bevacizumab and VEGF-R2 neutralizing antibodies limited the survival of hypoxic Etoposide-resistant cells [26].